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Abstract
Omics data facilitate the gain of novel insights into the pathophysiology of diseases and, conse-
quently, their diagnosis, treatment, and prevention. To that end, it is necessary to integrate omics
data with other data types such as clinical, phenotypic, and demographic parameters of categorical
or continuous nature. Here, we exemplify this data integration issue for a study on chronic kidney
disease (CKD), where complex clinical and demographic parameters were assessed together with
one-dimensional (1D) 1H NMR metabolic fingerprints.
Routine analysis screens for associations of single metabolic features with clinical parameters,
which requires confounding variables typically chosen by expert knowledge to be taken into account.
This knowledge can be incomplete or unavailable.
The results of this article are manifold. We introduce a framework for data integration that
intrinsically adjusts for confounding variables. We give its mathematical and algorithmic founda-
tion, provide a state-of-the-art implementation, and give several sanity checks. In particular, we
show that the discovered associations remain significant after variable adjustment based on expert
knowledge. In contrast, we illustrate that the discovery of associations in routine analysis can be
biased by incorrect or incomplete expert knowledge in univariate screening approaches. Finally, we
exemplify how our data integration approach reveals important associations between CKD comor-
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bidities and metabolites. Moreover, we evaluate the predictive performance of the estimated models
on independent validation data and contrast the results with a naive screening approach.
1 Introduction
The advent of new omics technologies, offering high coverage at an affordable price, has changed the
landscape of large-scale clinical studies. More and more population-based trials collect not only infor-
mation about phenotypes, traditional clinical parameters, and demographic variables, but also extensive
omics data, e.g. KORA [1, 2], and TwinsUK [3]. This typically results in a large set of complex patient
data, which needs to be statistically analyzed.
One example of such a large-scale, population-based study is the German Chronic Kidney Disease
(GCKD) study, comprising about 5200 chronic kidney disease (CKD) patients. CKD constitutes one of
the largest burdens on the world’s health system [4], with about 200 cases per million per year in many
countries [5], and a global occurrence of 50% in high-risk subpopulations [6]. As it progresses, CKD leads
to a large number of adverse clinical symptoms, and in some cases may progress to complete renal failure,
called end-stage renal disease (ESRD) [7]. It is linked to elevated all-cause and cardiovascular mortality,
acute kidney injury (AKI), cognitive decline, anemia, mineral and bone disorders, and fractures [4, 7, 8].
Moreover, it is often accompanied by numerous other systemic diseases, such as cardiovascular disease,
hypertension, obesity, and diabetes [6, 9, 10].
The GCKD study was designed to improve our understanding of the causes, course, and risk factors
of progressive kidney insufficiency [11]. To that end, demographic, phenotypic, and clinical parameters of
approx. 5200 CKD patients were assessed [11, 12]. Additionally, NMR metabolic fingerprints of plasma
specimens collected at the study baseline were acquired for almost the complete cohort. Metabolic mark-
ers are expected to better reflect the current state of the kidney than, e.g., genomic, transcriptomic, or
proteomic markers [13]. In total, approximately 900 parameters of diverse data sources, which poten-
tially have complex dependencies amongst each other, have been assembled. Here, we aim to identify, in
the best case yet unknown, relationships between these complex layers of information. Particularly, we
aim to uncover metabolic features related to CKD and its diverse comorbidities.
Data integration tries to detect such relationships. However, it presents both a conceptual and a
practical challenge. Conceptually, we are faced with complex, often synergistic effects between variables
within and across different layers of information, where the variables are potentially of different data
types. Practically, we have to deal with a large-scale dataset covering close to thousand variables and
several thousand measurements, leaving the researcher with a lot of possible hypotheses that require
extensive validation. The practical and conceptual issues are inseparably connected. Assuming more
complex and realistic models requires more parameters and their estimation becomes computationally
more and more challenging.
Numerous methods have been proposed to analyze complex datasets, ranging from metabolome-
wide association studies and multivariate statistical analysis to data-driven network-based approaches
[14, 15]. Metabolome-wide association studies are applied routinely to identify associations between
metabolites and phenotypes, but they inherently ignore complex, multivariate relationships between
variables. Approaches based on probabilistic graphical models can reveal complex relationships, but they
are usually limited to one specific data type, e.g., Gaussian Graphical Models (GGMs) for continuous
(Gaussian) variables or discrete Markov Random Fields (dMRF) for categorical variables [16]. More
recently, probabilistic graphical models have been extended to include different data types simultaneously
[16, 17], although such methods have not yet entered biomedical research.
Univariate screening approaches ignore effects of confounding variables. These can be either incorpo-
rated by correcting the data or by adapting the statistical test. Formally, this corresponds to estimating
the partial correlation coefficient ρXY ·Z, which denotes the partial correlation between X and Y given
the confounders Z. If ρXY ·Z 6= 0, then there is an association between X and Y given Z, where the size
and sign of ρXY ·Z reflects the strength and sign of an association, respectively. An inherent problem in
the estimation of ρXY ·Z is that it is not a priori clear which variables to include in Z. To solve this issue,
we need to estimate ρXY ·Z, where Z includes all assembled variables except X and Y , ideally containing
the complete confounder set.
Here, we estimate ρXY ·Z, where X, Y , and Z are the comprehensive patient data assembled within
the GCKD study. The included variables are either continuous or categorical. Thus this analysis requires
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the estimation of a so-called Mixed Graphical Model (MGM) [16, 17]. We first show how this integrative
analysis reveals known relationships between variables. Second, we illustrate that the discovery of asso-
ciations in univariate screening approaches is biased by incorrect or incomplete expert knowledge. Third,
we demonstrate that our data integration approach overcomes this issue. Finally we give an example,
where important associations between CKD comorbidities and metabolites are revealed. Here, we show
that the discovered associations remain significant after variable adjustment based on expert knowledge.
Throughout the article, we substantiate our findings by evaluating the predictive performance of the
estimated model on validation data.
2 Materials and methods
2.1 Mixed Graphical Models
MGMs are undirected probabilistic graphical models, where the conditional dependencies between differ-
ent variables, the so-called nodes or vertices, are represented as edges in a network. Thus, two nodes are
connected by an edge only if their association or interaction cannot be explained by any other node in
the graphical model, or equivalently, if their partial correlation coefficient is unequal zero. Consequently,
probabilistic graphical models eliminate spurious associations between variables and can potentially re-
veal new associations adjusted for all other variables in the dataset.
2.2 Algorithmic implementation
For the current dataset, which included 879 variables and 3705 patients (measurements), we needed to
estimate, in total, 388521 edge weights.
Therefore, we implemented an efficient algorithm to estimate MGMs as described in the supplemen-
tary methods section 6.5. Here, we used the pseudo-log-likelihood method of [17], made use of proximal
algorithms to include a LASSO penalty on the parameters [18], and we performed the proximal gradient
descent using Nesterov acceleration and adaptive restarts [19, 20]. The respective Python scripts to
estimate MGMs are available upon request.
2.3 Data integration workflow
A schematic illustration of our data integration workflow is shown in Figure 1. Starting point is the
GCKD study, Figure 1a. Here, we included a total of 3705 GCKD study participants. The remaining
study participants had to be excluded due to missing demographic, clinical, and/or metabolic data. We
generated a training set of 2470 study participants, corresponding to 2/3 of the complete cohort, and a test
set of 1235 study participants, respectively, compare to Figure 1b. For the current study, we included 17
clinical chemistry parameters, 73 demographic parameters, and 46 different drug treatments, all assessed
at the study baseline. Each of the three different information layers is represented by a blue, orange, and
cyan schematic data matrix in Figure 1b, respectively. These parameters, their distributions, assessment,
as well as transformation information are given in Supplementary Table S1. For each study participant,
a one-dimensional (1D) 1H nuclear magnetic resonance (NMR) spectrum of a baseline EDTA plasma
specimen was acquired. In total, 743 metabolic features were extracted from the spectra, as described
in the supplementary methods section 6.4. This information layer is represented by the red data matrix
in Figure 1b. In summary, the complete variable space included 879 variables, with 768 continuous and
111 discrete variables, respectively.
Next, the MGM was estimated on the training data, Figure 1c, and validated on independent test
data, Figure 1d. Here and throughout the article, clinical chemistry parameters are represented as blue
nodes, demographic variables as orange nodes, drug treatment information as cyan nodes, and NMR
buckets as red nodes. Positive and negative associations are shown as blue and red edges, respectively,
where the edge width encodes the absolute edge strength. Continuous variables are shown as circles and
discrete variables as rectangles.
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Figure 1: Scheme of the Mixed Graphical Model (MGM) data integration approach. (a) Of the data ascertained from the
GCKD study population, (b) a total of 17 clinical chemistry parameters (blue), 73 demographic parameters (orange), 46
drug treatment parameters (cyan), and 743 NMR spectral features (red) were chosen. The complete dataset was split into a
training and a test cohort, respectively. The first (c) was used to estimate an MGM, modeling all conditional dependencies
between all variables, whereas the latter (d) was used for MGM model validation. In the network representation of
the estimated MGM, blue nodes represent clinical chemistry parameters, orange nodes represent demographic variables,
cyan nodes represent drug treatment information, and red nodes correspond to NMR buckets. Continuous variables are
represented as circles and discrete variables as rectangles. Positive and negative associations are shown as blue and red
edges, respectively. The strength of the association, i.e., the weight of the corresponding coefficient, is encoded by the edge
width.
3 Results
3.1 MGM data integration reveals known associations and combines them
to reliable prediction models
First, we will present several sanity checks for our MGM approach. We will illustrate how the MGM
reveals known associations in the context of the two renal function markers urinary albumin-to-creatinine
ratio and the glomerular filtration rate, for two frequent comorbidities, i.e. diabetes and gout, and for a
lifestyle factor, i.e. alcohol consumption.
Urinary albumin-to-creatinine ratio The urinary albumin-to-creatinine ratio (UACR) and the
glomerular filtration rate (GFR) are the two most important markers of renal function routinely as-
sessed in CKD patients. Figure 2a visualizes the first order neighborhood of UACR. The first order
neighborhood of a node comprises all other nodes that have a direct association/edge with this particu-
lar node. The MGM trained on the training set connects UACR with urinary albumin (ua) by a strong
positive edge, and with urinary creatinine (ucrea) by a strong negative edge, respectively. This correctly
reflects the definition of UACR, log2(UACR) = log2(ua/ucrea) = log2(ua)− log2(ucrea).
A third positive edge appears between ua and ucrea. This edge can be explained within the condi-
tional dependence framework: two variables are conditionally dependent on each other, if both variables
simultaneously change upon holding all other variables fixed. Let the value of UACR be fixed and change
the value of ua. In order to fulfill the requirement that the UACR stays fixed, urinary creatinine has
to change accordingly to compensate the changes of urinary albumin and, thus, a positive edge appears
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Figure 2: (a) First order neighborhood of urinary albumin-to-creatinine-ratio (UACR). The first order neighborhood of
a node comprises all other nodes which have a direct association/edge with this particular node. Positive associations are
represented as blue, negative associations as red edges, respectively. The strength of the estimated association is encoded
by the edge width. The edges are ordered according to their strength in a clock-wise manner for positive, and in an anti-
clock-wise manner for negative associations, respectively. UACR is positively associated with urinary albumin (ua) (edge
weight = 22.85) and negatively associated with urinary creatinine (ucrea) (edge weight = -7.19), respectively. The positive
edge between ua and ucrea (edge weight = 7.31) can be explained within the conditional dependence framework (see text).
Two levels of proteinuria are connected to both UACR and ua, respectively. High level of protein in the patient’s urine
(proteinuria > 300mg/dL) is positively correlated, whereas proteinuria of less than 30mg/dL (proteinuria < 30mg/dL) is
negatively correlated with UACR (edge weight = 0.573 and edge weight = -0.564, respectively) and ua (edge weight =
2.873 and edge weight = -3.53, respectively), respectively. Moderate proteinuria (30mg/dL < proteinuria < 300mg/dL)
was considered as the baseline. (b) First order neighborhood of eGFR values estimated by the CKD-EPI equation based on
serum creatinine (eGFR). eGFR is strongly negatively associated with serum creatinine (crea) (edge weight = -11.185),
strongly positively associated with male gender (gender) (edge weight = 7.514), and negatively associated with age (age)
(edge weight = -2.713). Negative associations are revealed between eGFR and serum cystatin C values (CysC) (edge
weight = -0.764), and the NMR bucket at 3.045ppm (edge weight = -0.374), corresponding to creatinine, respectively. A
complete list of all abbreviations for the clinical parameters can be found in Supplementary Table S1.
between ua and ucrea.
We further observe positive edges between severe proteinuria (proteinuria > 300mg/dL) and ua as
well as UACR, respectively, correctly stating that patients with high urinary levels of albumin and ac-
cordingly high UACR values are diagnosed with proteinuria. Correspondingly, absent or mild proteinuria
(proteinuria < 30mg/dL) is negatively associated with urinary albumin and UACR. Here, intermediate
proteinuria (30mg/dL < proteinuria < 300mg/dL) was considered as the baseline.
In a second step, we validated the predictive performance of the detected neighborhood. For this
purpose, we used the respective edge weights as a linear signature that predicts UACR. As shown in
Figure 3a, the identified neighborhood is almost perfectly predictive of UACR on independent test data
with a correlation coefficient between true and predicted UACR values of cor ∼ 1.
Glomerular filtration rate (GFR) The GFR defines the fluid volume filtered by the glomeruli per
unit time. Several formulas are available to estimate the GFR. Here, we included estimated GFR (eGFR)
values calculated using the CKD-EPI equation [21].
CKD-EPI takes as input serum creatinine (crea), age, gender, and race. In Figure 2b, we show the
first order neighborhood of eGFR, which correctly identified age, gender, and serum creatinine. Race
was not included as a variable, as all GCKD study participants were Caucasian, and, thus, the respective
connection could not be observed.
In addition, we observed associations of eGFR with cystatin C (cysC ), and NMR buckets assigned
to creatinine (3.045 ppm, 4.055 ppm, and 4.065 ppm). Serum cystatin C, besides serum creatinine, is
used as an endogenous marker to estimate GFR, e.g. in the CKD-EPI equation based on cystatin C [22],
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Figure 3: (a) The diagram shows the predictions of UACR on the y-axis (in standard units [su]) based on the neighbors
of UACR, compare to Figure 2a, on independent test data compared to the true values plotted on the x-axis. (b) Shows
the analogous plot for eGFR. In both scenarios, predictions agree almost perfectly with the true values as indicated by
the correlation coefficients cor between true and predicted values given in the lower right corners. The receiver operating
characteristic (ROC) curve for predicting elevated blood sugar based on its neighborhood, as shown in Figure 4a, is shown
in (c). The x-axis here represents the false, whereas the y-axis represents the true positive rate, respectively. The dashed
line gives the diagonal, corresponding to the predictive performance of a randomly generated model. In the lower right
corner, the area under the ROC curve (AUC), an indicator of the predictive power of a classifier, is given. A perfect
classifier would achieve an AUC of 1 on independent test data, whereas a randomly generated classifier with no predictive
power would achieve an AUC of 0.5, respectively. (d) shows the ROC curve for the neighborhood model of the medical
diagnosis of a patient as being diabetic.
which explains the found association between cystatin C and eGFR.
In Figure 3b, we show how the neighborhood of eGFR predicts eGFR on test data. We observe that
values agree with a correlation coefficient of cor = 0.995.
Diabetes One of the most common comorbidities of CKD is type-2 diabetes mellitus (T2DM). Un-
treated T2DM is characterized by high blood glucose. In this study, blood sugar is included as the
discrete variable “elevated blood sugar yes/no” (bl sug).
The MGM correctly identifies NMR buckets corresponding to D-glucose signals, namely 3.785 ppm,
3.865 ppm, 3.875 ppm, and 3.765 ppm, in the first-order neighborhood of “elevated blood sugar yes/no”,
Figure 4a. The three strongest connections are between elevated blood sugar and diabetes medica-
tions (med dm), the classification as diabetes patient (diabetic), and diabetic nephropathy (diab neph),
respectively.
In Figure 4b, we show the first-order neighborhood of diabetic, which exhibits a strong connection to
diabetes medications (med dm) and glycated hemoglobin (HbA1c) (hba1c). This reflects the definition
of a diabetic patient within this study: a patient is defined as diabetic, if he had an HbA1c value ≥
6.5% or took at least one medication with an active component classified as “A10”, i.e. insulin and other
diabetes medications. HbA1c reflects the two to three month average plasma glucose level [23] and is
here associated with elevated blood sugar independently of diagnosed diabetes.
Other strong connections were observed between blood sugar and retinal laser therapy due to diabetes
(ret las), as well as classification as T2DM patient (dm typ2 ). All three variables are positively connected
to diabetic nephropathy (diab neph), as a study participant is stated to suffer from diabetic nephropathy,
if he/she suffers from type-1 or type-2 DM or from other diabetic nephropathies.
The corresponding neighborhoods of bl sug and diabetic are highly predictive. The areas under the
receiver operating characteristic (AUC-ROC) curves are 0.936 and 0.996 on the test data, as shown in
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Figure 4: (a) First order neighborhood of elevated blood sugar (bl sug) and (b) classification as diabetic patient
(diabetic). Strong associations can be observed between bl sug and diabetes medications (med dm) (edge weight = 1.52),
diabetic (edge weight = 1.27), and diabetic nephropathy (diab neph) (edge weight = 1.15), respectively. Other strong
associations are present between diabetic and med dm (edge weight = 2.89), and the HbA1c value (hba1c) (edge weight
= 2.366), respectively, as well as between 2 NMR buckets at 3.785ppm (edge weight = 0.136) and 3.865ppm (edge weight
= 0.134), both corresponding to D-glucose, and bl sug, and between diab neph and classification as type-2 DM patient
(dm typ2 ) (edge weight = 7.1) and retinal laser therapy due to diabetes (ret las) (edge weight = 0.47), respectively.
Figure 3c and d, respectively.
Gout Gout is a common comorbidity in CKD patients [24, 25]. The first order neighborhood of gout
(gout) as shown in Figure 5 comprises a number of clinical and metabolic variables. This phenotype
exhibits strong positive associations with the NMR buckets at 8.115 ppm and 8.125 ppm corresponding
to unidentified small peptides. An NMR bucket at 3.565ppm, which could be assigned to glycine, is
strongly negatively associated with gout.
Glycine has been reported to negatively correlate with gout in other metabolic studies [26]. It is
involved in purine metabolism and is a precursor of uric acid [26]. Decreased plasma levels of glycine in
patients with gout might be caused by the increased production of uric acid in these patients [26]. Note
that uric acid has also been positively associated with gout in our study.
Interesting associations between gout and clinical variables are present for high alcohol consumption
(positive association), analgetic nephropathy (an neph) (positive association), bmi (positive association),
microscopic polyangiitis (mic polyang) (negative association), anti-dementia medication (med antidemenz)
(positive association), waist-hip ratio (wh ratio) (positive association), and Morbus Wegener (negative
association). Alcohol consumption, age (here positively associated with gout), male gender (here weakly
positively associated with gout), loop diuretica (here positively associated), and obesity are known risk
factors of gout [27, 28].
The first order neighborhood of gout is predictive on independent test data with an AUC of 0.748,
compare to Figure 6a.
Alcohol consumption The assessment of alcohol consumption in the GCKD cohort was based on a
questionnaire about weekly alcohol intake. Study participants, who had stated to consume alcohol not
more than twice a week were classified as “little or normal alcohol consumption”, here treated as the base-
line level, and all other study participants were classified as “high alcohol consumption”. Supplementary
Figure 12 displays the first order neighborhood of “high alcohol consumption”. Interestingly, high alco-
hol consumption is strongly positively associated with male gender, acute renal failure (acute fail), high
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Figure 5: First order neighborhood of gout (gout). Strong positive associations between this phenotype and the NMR
bucket at 8.115 ppm (edge weight = 0.272), corresponding to unidentified small peptides, alcohol (edge weight = 0.202),
8.125 ppm (edge weight = 0.194) (unidentified small peptides), as well as analgetic nephropathy (an neph) (edge weight =
0.169), and strong negative associations with the NMR bucket at 3.565 ppm (edge weight = -0.16), identified as glycine,
can be observed. Gout is also connected to bmi (edge weight = 0.15), anti-dementia medication (med antidemenz ) (edge
weight = 0.14), waist-hip ratio (wh ratio) (edge weight = 0.13), and Morbus Wegener (morb weg) (edge weight = -0.13).
density lipoprotein (hdl), an NMR bucket at 1.145 ppm, containing broad lipid signals mainly identified
as low density lipoprotein (LDL), two unidentified NMR buckets at 0.835 and 2.755 ppm, and an NMR
bucket at 2.675 ppm, identified as citric acid (negatively correlated). Further, it is positively associated
with an NMR bucket at 1.925 ppm, identified as acetate (major signal) and minor contributions from
arginine and lysine, and an NMR bucket at 3.275 ppm, identified as trimethylamine-N-oxide (TMAO)
and minor contributions from D-glucose and betaine.
Levels of large and medium-sized HDL as well as large LDL particles have been reported to be elevated
by alcohol consumption [29, 30]. It is also reported that alcohol consumption is generally higher in males
than in females [30]. Citric acid has been reported to negatively correlate with alcohol consumption in
other studies [31].
As shown in Figure 6b, the first order neighborhood of high alcohol consumption is predictive on
independent test data with an AUC of 0.796.
3.2 Associations in univariate screening approaches can be biased by incor-
rect or incomplete expert knowledge, while MGMs intrinsically account
for confounding variables
Here, we compare two different approaches to screen for associations, i.e. a standard univariate regression
and the MGM data integration approach. We will illustrate that the associations discovered by the MGM
are more robust for post hoc confounder adjustment than univariately screened associations.
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Figure 6: Receiver operating characteristics (ROC) curves for predicting (a) gout, (b) high alcohol consumption, (c)
cardiac arrhythmia (card arr), and (d) cardiac infarction (card inf) based on their respective first order neighborhoods
on independent test data. The corresponding area under the ROC curve (AUC) values are given in the lower right corners.
3.2.1 Univariate screening
We first screened for univariate associations between variables by regressing each variable on every
single remaining variable in the dataset. We performed linear or logistic univariate regression analysis,
depending on whether the response variable followed a Gaussian or a binomial distribution, respectively.
For each response variable, we ranked the univariate predictor variables according to their association
strength in terms of significance, here − log10(p-values). The predictor with the largest − log10(p-value)
was considered as the “top association”. Figure 7a column “top assoc.” shows the distribution of
− log10(p-values) of all top associations.
Next, we repeated the regression analysis, but now in a multivariate fashion, simulating a regression
analysis with confounder adjustment. We regressed each variable on its ”top associated” variable and
on the next five most significant predictors simultaneously, and recorded the − log10(p-value) of the ”top
associated” variable. The corresponding distribution is shown in Figure 7b “top assoc.”. We observe
that the associations appear substantially weaker after variable adjustment. This trend is also visible
from Figure 9a, where we contrast adjusted (y-axis) with unadjusted (x -axis) − log10(p-values). Here,
we obtained almost exclusively values in the upper half plane, see also Figure 10a. Finally, we regressed
each response variable on its ”top associated” predictor and on five additional variables randomly drawn
out of the next top 10 univariate predictors. The corresponding distribution can be found in Figure
7c “top assoc.”. Again, − log10(p-values) of the top associations in this multivariate regression scenario
appear much weaker than in the univariate screening of Figure 7a.
3.2.2 Associations in MGMs are intrinsically corrected for confounding variables
We performed an analogous analysis for our MGM approach, but now, we ranked the predictors of
each response variable according to their edge weights (from largest to lowest absolute value). The
predictor with the largest absolute coefficient was considered as the “top neighbor”. In a post-hoc
analysis, we regressed each response variable on its top MGM neighbor, and show the distribution of
corresponding − log10(p-values) in Figure 7a, column “top neighbor”. Figure 7b, column “top neighbor”
shows − log10(p-values) for these top MGM neighbors, but now adjusted for the next top 5 neighbors
in the respective MGM neighborhood. We observe that the significance decreases, as previously for the
univariate screening, albeit, this effect is less pronounced (Figure 7b). If we adjust for the same randomly
drawn features as for the univariate approach, we obtain the results in Figure 7c, which show the same
trend. For Figure 8a to c, we subtracted the left values (“top assoc.”) from the right values (“top
neighbor”) in Figure 7a to c, respectively. In addition, we contrast those differences with their respective
rank as red points. The x-axis now corresponds to the rank percentiles, starting with the most negative
difference at 0, and the highest positive difference at 1, respectively.
In Figure 8a, all differences are at or below zero. Approx. 42% of the difference values are negative
(see green highlighted area), and the remaining differences are zero. After confounder adjustment,
Figure 8b, the differences are predominantly positive. Considering the rank distribution, 70% of the
difference values are positive (highlighted by the violet area), and only 30% are negative (highlighted
by the green area). This indicates, on average, a higher significance of the top features selected by the
MGM after variable adjustment. Figure, 8c shows the corresponding results after an adjustment for the
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Figure 7: Effects of variable adjustment on univariate or MGM association analysis in the training set. (a) “top assoc.”
shows the distribution of − log10(p-values) derived from a univariate regression. Here, we calculated p-values between all
possible pairs of variables and collected all top associations. “top neigh.” shows the analogous distribution, where the top
feature was selected by largest absolute edge weight in the MGM neighborhood. (b) The corresponding plot, where the
p-values were corrected by the top five confounder variables of the univariate and MGM screening, respectively. (c) The
corresponding plots, where we adjusted for the same five randomly selected features for both methods.
same randomly selected features for “top assoc.” and “top neighbor”. Now, 30% of the differences are
positive, only 12% are negative, and most of them are equal to zero.
3.2.3 MGMs can reveal associations which remain hidden or underestimated in univariate
approaches
In Figure 9b we contrast adjusted with unadjusted values of − log10(p-values) for the MGM approach. We
observe that several variables are stronger associated with each other after variable adjustment compared
to the unadjusted scenario. This is in contrast to the univariate approach, Figure 9a, where almost all
values were located in the upper half plane. A comparison between unadjusted and randomly adjusted
− log10(p-values) for the univariate and the MGM approach can be found in Supplementary Figure 13.
An interesting example, how an association is revealed in a multivariate context, can be observed in
the context of gout. One of the most important associations in the neighborhood of gout is alcohol, which
was only ranked at position 216 in the univariate screening. Gender, in contrast, whose association is on
rank 6 in a univariate screening, appears only at position 26 in the MGM. Thus, we can speculate that
the prevalence between gout and male gender can be explained to a large extend by the higher alcohol
consumption in males.
Plots corresponding to Figures 7, 8, and 9 for the validation data are shown in Supplementary Figures
14, 15, and 16, and strongly support our observations.
3.3 TMAO is associated with cardiac infarction and cardiac arrhythmia
Cardiovascular diseases and complications are typical comorbidities and outcomes in patients with CKD.
Here, we focus on the first order neighborhood of two common phenotypes in CKD patients, i.e., cardiac
arrhythmia (card arr) and cardiac infarction (card inf ), shown in Figure 11a and b, respectively. Both
variables are explained by a number of demographic and drug information parameters.
Patients who were diagnosed with cardiac arrhythmia, compare to Figure 11a, received vitamin K
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Figure 8: (a) to (c) show the differences between “top neigh.” and “top assoc.” in Figure 7a to c, respectively:
(a) shows the − log10(p-values) of the MGM approach minus those of the univariate screening in Figure 7a, (b) shows the
corresponding plot after adjusting for the respective top confounders, as shown in Figure 7b, and (c) shows the corresponding
plot after adjusting for the randomly selected confounders, as shown in Figure 7c. The red points in each figure contrast
the values on the y-axis with their respective rank. On the x -axis, the highest positive difference corresponds to 1 and the
most negative to 0. The green shaded areas correspond to rank percentiles of negative, the violet shaded areas correspond
to rank percentiles of positive differences, respectively.
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Figure 9: Smooth scatter plot of adjusted p-values (x -axis) versus unadjusted (univariate) p-values (y-axis) for the
univariate screening (a), and the MGM (b) in the training set. The red rectangle marks an excerpt shown in detail in
Figure 10.
antagonists (med vitK ant) (positively associated), had experienced a heart failure (card ins) (positively
associated) and mitral valve insufficiency (mit ins) (positively associated), experienced angina pectoris
(br pain) (positively associated), and dyspnea during physical strain (dyspn str) and during the night
(dyspn) (both positively associated), got a diagnosis of other heart valve anomalies (oth ins) (positively
associated), and received antithrombotic drugs (med antipl) (positively associated).
Patients, who suffered a cardiac infarction, see Figure 11b, were likely (positively associated) to have
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Figure 10: The region marked by a red rectangle in Figure 9 for the univariate screening (a), and for screening by the
MGM (b) in the training set. Adjusted p-values are shown on the x -axis, unadjusted p-values on the y-axis.
received a diagnosis of coronary angiopathy (cor ves enl), to have undergone cardiac surgery (card surg),
were less likely to have been diagnosed with aortic valve stenosis (ao sten) (negatively associated),
suffered from CKD due to acute renal failure events (acute fail) (positively associated), were likely to
have experienced angina pectoris (br pain) and heart failure (card ins), and to have received antiplatelet
therapy (med antipl agg). They were also likely to have underwent a catheter angiography of peripheral
arteries including an angioplasty of a peripheral artery (cont ag), to suffer from mitral valve insufficiency
(mit ins), or a stroke (stroke), and they also had lower serum cholesterol levels (chol) (negatively
associated).
Most interestingly, both cardiac infarction and cardiac arrhythmia were positively associated with
an NMR bucket at 3.275 ppm, which could be identified as trimethylamine-N-oxide (TMAO) and minor
signals from D-glucose and betaine.
Increased plasma levels of TMAO have just recently been described as a marker for atrial fibrillation
independent of hypertension, BMI, smoking, diabetes, or intake of total choline [32], and have been
associated with a higher incidence of major adverse cardiovascular events (death, myocardial infarction,
or stroke) [33].
Supplementary Figure 17 displays the distribution of NMR signal intensities at 3.275 ppm for both
patients without and with cardiac arrhythmia for training and test data, respectively. Comparing both
distributions by a Student’s t-test yields a p-value of 5.3·10−10 and 6.8·10−6 for the training and test
cohort, respectively. To explore possible confounding effects, we adjusted the NMR bucket intensities
of 3.275 ppm for hypertension, BMI, smoking, and diabetes, which have been reported as confounders
in [32]. Intake of total choline was not accessed in the GCKD study and could therefore not be used
for confounder adjustment. The corresponding boxplots for the residuals of NMR bucket intensities at
3.275 ppm are shown in Supplementary Figure 17(b) and (d), respectively. The p-values comparing the
cardiac arrhythmia with the non-cardiac arrhythmia group are still significant with values of 2.3·10−7
and 0.012 for training and test set, respectively.
The first order neighborhoods of cardiac arrhythmia and cardiac infarction are highly predictive on
independent test data with AUCs of 0.80 and 0.93, respectively, compare to Figure 6 (c) and (d).
4 Discussion
We have shown that MGMs are a versatile tool for the integration of both continuous (Gaussian) and
categorical variables. Here, we used data collected from patients that suffered from CKD and included
variables comprising clinical and demographic parameters, medications, and blood plasma metabolites
assessed by NMR spectroscopy. We could reveal several known relationships, such as the definitions
of UACR, eGFR, and diabetes. More interestingly, we observed complex associations between plasma
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Figure 11: First order neighborhood of (a) cardiac arrhythmia (card arr) and (b) cardiac infarction (card inf). card arr
is strongly connected to vitamin K antagonists (med vitK ant) (edge weight = 1.50), heart failure (card ins) (edge weight
= 1.0), mitral valve insufficiency (mit ins) (edge weight = 0.52), angina pectoris (br pain) (edge weight = 0.39), dyspnea
during physical strain (dyspn str) (edge weight = 0.38) and during the night (dyspn) (edge weight = 0.26), other heart valve
anomalies (oth ins) (edge weight = 0.18), anti thrombotic drugs (med antipl) (edge weight = 0.17), underwent temporary
dialysis (temp dial), and were positively associated with an NMR bucket at 3.275ppm (edge weight = 0.12), identified as
trimethylamine-N-oxide (TMAO) and minor signals of D-glucose and betaine. card inf is strongly connected to coronary
angiopathy (cor ves enl) (edge weight = 1.80), underwent cardiac surgery (card surg) (edge weight = 1.32), aortic valve
stenosis (ao sten) (edge weight = -0.65), acute renal failure (acute fail) (edge weight = 0.55), angina pectoris (br pain)
(edge weight = 0.49), heart failure (card ins) (edge weight = 0.43), antiplatelet therapy (med antipl agg) (edge weight =
0.41), underwent catheter angiography of peripheral arteries including angioplasty of a peripheral artery (cont ag) (edge
weight = 0.21), mitral valve insufficiency (mit ins) (edge weight = 0.20), stroke (stroke) (edge weight = 0.19), serum
cholesterol levels (chol) (edge weight = -0.16), anti thrombotic drugs (med antipl) (edge weight = 0.16), and an NMR
bucket at 3.275ppm (edge weight = 0.14).
metabolites and comorbidities like gout and cardiac disorders. Moreover, we could validate those asso-
ciations on test data.
Emerging datasets provide more and more layers of information, which makes data analysis increas-
ingly complex. This high complexity leaves the researcher with an overwhelming amount of possible
hypotheses, which require extensive tests and validations. Thus, there is an urgent need for automated
tools that hint towards interesting observations. Here, MGMs are predestined, because they condense
the available data into graphs that researchers can easily read and interpret. Moreover, MGMs consider
the whole system of variables and measurements simultaneously. As a consequence, they correct for
confounding factors, such as age, gender, and medications, automatically. Thus, if the MGM observes
an interesting association, it is likely not a bystander effect of other variables if those are part of the
analysis itself. We showed this in a scenario where we corrected for artificially selected confounders.
Particularly, we could demonstrate that confounder adjustment can be necessary to reveal associations,
as we exemplified for the association of gout with high alcohol consumption. Finally, we illustrated that
the MGM discovered an association of TMAO with cardiac arrhythmia, which remains significant after
adjustment for variables selected by expert knowledge.
MGMs are undirected graphical models. Thus, they do not include information about causality. In
the context of Gaussian graphical models, there are plenty of works that estimate causal relations from
observational data only [34, 35, 36]. Combining those methods with MGMs could further strengthen our
data integration approach.
In summary, we tested MGMs for the integrative analysis of categorical and continuous variables in
the context of CKD. We illustrated its application, provided software to estimate MGMs, and exemplified
their interpretation. Moreover, we have reported interesting associations between plasma metabolites
and the CKD comorbidities gout and cardiac disorders.
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6 Supplementary materials and methods
6.1 Cohort description
The study cohort comprises 3705 participants of the German Chronic Kidney Disease (GCKD) study,
whose detailed baseline clinical and demographic characteristics are described elsewhere [11, 12]. Written
declarations of consent had been obtained from all study participants before inclusion. From each patient,
one EDTA-plasma specimen had been collected at the baseline time-point and stored at -80◦C until NMR
measurement.
6.2 Clinical and demographic variables
For this study, we included 17 clinical chemistry parameters measured by SYNLAB International GmbH
(Munich, Germany) and Central Lab, University Hospital Erlangen, Germany [12], 73 demographic
parameters including age, sex, disease history and lifestyle factors, and 46 different drug treatments,
resulting in a total of 136 clinical variables. Supplementary Table S1 provides a list of all included
variables, their corresponding distributions, as well as assessment information.
6.3 NMR spectroscopy
For NMR measurements, 400 µL of unfiltered EDTA-plasma were mixed with 200 µL of 0.1 mol/L phos-
phate buffer at pH 7.4, 50 µL of 0.75% (w) 3-trimethylsilyl-2,2,3,3-tetradeuteropropionate (TSP) dis-
solved in deuterium oxide, and 10 µL of 81.97 mmol/L formic acid (all from Sigma-Aldrich, Taufkirchen,
Germany), the latter serving as internal standard for referencing and quantification [37]. NMR experi-
ments were carried out on a 600 MHz Bruker Avance III (Bruker BioSpin GmbH, Rheinstetten, Germany)
employing a triple-resonance (1H, 13C 31P, 2H lock) cryogenic probe equipped with z-gradients and an
automatic cooled sample changer. Since the presence of broad protein signals might hinder the inter-
pretation of metabolite signals, 1D 1H spectra employing a Carr-Purcell-Meiboom-Gill (CPMG) pulse-
sequence for the suppression of macromolecular signals were acquired for each EDTA-plasma specimen.
For each 1D 1H CPMG spectrum, 128 scans were collected into 73728 data points employing presatura-
tion during relaxation for water suppression. Four dummy scans were acquired prior to measurement,
the spectral width was 20.02 ppm, the relaxation delay was 4 s and the acquisition time amounted to
3.07 s. The filtering delay amounted to 0.08 s, resulting in a total acquisition time of about 16 min per
sample.
NMR signals were assigned to known metabolites by comparison with reference spectra of pure com-
pounds acquired under equal experimental conditions employing the Bruker Biofluid Reference Com-
pound Database BBIOREFCODE 2-0-3 [38].
6.4 Data preprocessing
All continuous clinical and demographic variables except for age, systolic and diastolic blood pressure
were log2 transformed to remove heteroscedasticity. Recoding of discrete variables is detailed in Supple-
mentary Table S1. In summary, we included 25 continuous and 111 discrete clinical and demographic
variables, respectively.
All NMR spectra were referenced with respect to the formic acid signal at 8.463 ppm. Since signal posi-
tions between spectra may be subject to minor shifts due to slight differences in pH, salt concentration,
and/or temperature between samples, equidistant binning was employed to compensate for these effects.
The spectral region from 9.5 - 0.5 ppm was evenly split into 900 bins of 0.01 ppm width using Amix
VIEWER 3.9.13 (Bruker BioSpin GmbH, Rheinstetten, Germany). All spectral data were scaled relative
to the formic acid signal from 8.5 - 8.45 ppm in order to reduce variations in spectrometer performance.
NMR buckets corresponding to the remainders of the suppressed water signal as well as minor contri-
butions from urea (6.0 - 4.5 ppm), formic acid (8.47 - 8.45 ppm), as well as dimethylamine (2.73 - 2.72
ppm) have been excluded prior to data analysis, resulting in a total number of 743 NMR buckets.
For further analysis, data were imported into R version 3.2.1 (Development Core Team 2009). To min-
imize heteroscedasticity of the NMR data, bucket intensities were log2 transformed and additionally
subjected to mean-value subtraction.
All continuous variables were scaled to standard units.
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6.5 Mixed Graphical Models
6.5.1 Probability density function
Integration of all discrete and continuous variables is achieved by estimating the conditional dependencies
between them by a Mixed Graphical Model (MGM) [16]. MGMs are undirected probabilistic graphical
models, where each node corresponds to one variable, and the edges between two nodes represent a
conditional dependency between them given all other variables in the graphical model. If there exists no
edge between two nodes, these two variables are conditionally independent of each other given all other
variables in the MGM.
Lee and Hastie [39] proposed the following probability density function p (x, y; Θ) to describe a pair-
wise graphical model on continuous and discrete variables:
p (x, y; Θ) ∝ exp
(
− 1
2
p∑
s=1
p∑
t=1
βstxsxt +
p∑
s=1
αsxs
+
p∑
s=1
q∑
j=1
ρsj(yj)xs +
q∑
j=1
q∑
r=1
φrj(yr, yj)
)
. (1)
Here, xs denotes the sth of p continuous variables, yj denotes the jth of q discrete variables with Lj states,
βst represents the continuous - continuous edge, and αs the continuous node potential, respectively,
ρsj is the continuous - discrete edge potential, represented as a vector of size Lj , φrj is the discrete
- discrete edge potential, and Θ = [{βst}, {αs}, {ρsj}, {φrj}] summarizes the whole parameter space.
− 12
∑p
s=1
∑p
t=1 βstxsxt+
∑p
s=1 αsxs describes conditional dependencies between two continuous variables
xs and xt, corresponding to the probability density function of a Gaussian Graphical Model (GGM) [39].
If βst = 0, no edge between xs and xt appears in the MGM, indicating an independency between these two
nodes conditioned against all other nodes in the graphical model. Analogously,
∑q
j=1
∑q
r=1 φjr(yj , yr),
which corresponds to a discrete pairwise Markov Random Field [39], describes conditional dependencies
between two discrete variables yj and yr with Lj and Lr states, respectively. If all entries of the matrix
φrj are equal to zero, the two discrete variables are conditionally independent given all others. Finally,∑p
s=1
∑q
j=1 ρsj(yj)xs gives the conditional dependencies between a continuous variable xs and a discrete
variable yj , represented by a vector of size Lj . If all entries of this vector are equal to zero, the two
variables are conditionally independent given all other variables in the MGM. In summary, if the whole
parameter space Θ = [{βst}, {αs}, {ρsj}, {φrj}] is determined, we are able to fully describe all conditional
dependencies between all variables in the considered system, here the population under investigation in
the GCKD study, which can be represented in a network.
6.5.2 Pseudo-log-likelihood, LASSO penalty, and algorithmic implementation
A maximum likelihood estimate (MLE) of Eq. (1) requires a summation over all discrete states, which is
numerically only feasible for small numbers of discrete variables. As an alternative, we use the pseudo-
likelihood method of [39], where the negative pseudo log-likelihood is given by
L(Θ|x, y) = −
p∑
s=1
log p(xs|x\s, y; Θ)−
q∑
r=1
log p(yr|x, y\r; Θ) . (2)
Here, p(xs|x\s, y; Θ) is the conditional distribution of a Gaussian variable xs, and p(yr|y\r,, x; Θ) is the
conditional distribution of a discrete variable yr with Lr states:
p(xs|x\s, y; Θ) =
√
βss√
2pi
exp
(
−βss
2
(
αs +
∑
j ρsj(yj)−
∑
t 6=s βstxt
βss
− xs
)2)
,
p(yr|y\r,, x; Θ) =
exp
(∑
s ρsr(yr)xs + φrr(yr, yr) +
∑
j 6=r φrj(yr, yj)
)
∑Lr
l=1 exp
(∑
s ρsr(l)xs + φrr(l, l) +
∑
j 6=r φrj(l, yj)
) . (3)
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Note, that the pseudo-log-likelihood method does not require a summation over the whole state space,
which makes it computationally more tractable than MLE.
We augmented the pseuod-log-likelihood estimate of (2) by a LASSO penalty to calibrate overfitting
λ
 p∑
s=2
s∑
t=1
ωst|βst|+
p∑
s=1
q∑
j=1
ωsj |ρsj |1˜ +
q∑
j=2
j∑
r=1
ωrj |φrj |1˜
 . (4)
Here, we used the definitions
|φrj |1˜ =
Lr∑
l=1
Lj∑
m=1
|φrj(l,m)| and |ρj |1˜ =
Lj∑
l=1
|ρj(l)| . (5)
The weights wst, wsj , and wrj were chosen as
wst = σsσt , wsj = σs
√∑
a
pb(1− pb) ,
wrj =
√∑
a
pa(1− pa)
∑
b
qb(1− qb) , (6)
where σs is the standard deviation of the continuous variable xs and pa = Pr(yr = a) and qb = Pr(yj = b)
[39]. For the multinomial variables, our parameter space is redundant [39]. This was taken into account
by multiplying the penalty factors which correspond to baseline levels by a factor of 10. This forces their
couplings to zero.
Optimization problem Eq. (4) is convex [39] and can be efficiently solved by proximal algorithms.
We implemented our software in Python, with computationally expensive parts written in C. Here, we
used the Python package apgpy accessed under https://github.com/bodono/apgpy, which performs
the proximal gradient descent with Nesterov acceleration and adaptive restarts [20].
6.5.3 Calibration of the penalty parameter λ
We chose the penalty parameter λ according to the Extended Bayesian Information Criterion [40, 41]
EBICγ(E) = −2ln(Θˆ(E)) + |E| log n+ 4|E|γ logP, (7)
where γ is a parameter that can be chosen in the interval [0, 1], n is the number of measurements and P is
the number of variables. E is the set of edge parameters unequal to zero, and ln(Θˆ(E)) the corresponding
maximized pseudo-log-likelihood. For calculating both P and E we removed the baseline levels from the
adjacency matrix. The minimum of Eq. (7) determines the penalty parameter λ, which we estimated by
line search. This line search sweeps the λ-sequence λ0 ·22,1.75,1.5,1.25,...,−4.5,−4.75,−5, with λ0 =
√
log(p+q)
n .
Throughout the article, we discuss the model γ = 1, which corresponds to the sparsest model according
to EBIC. For visualization, we used the R packages qgraph [42] and igraph [43], where we transformed
the edge weights by the formula f(x) = log(1 + 10x).
6.6 Association analyses
Analysis were performed using the statistical analysis software R version 3.3.3. For logistic regression,
we used the R package logistf [44].
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7 Supplementary Figures
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Figure 12: First order neighborhood of high alcohol consumption (alcohol). Strong associations are observed between
high alcohol consumption and male gender (edge weight = 0.682), acute kidney failure (acute fail) (edge weight = 0.267),
high density lipoprotein (hdl) values (edge weight = 0.211), gout (edge weight = 0.202), an NMR bucket at 1.145 ppm (edge
weight = 0.19), containing broad lipid signals mainly identified as low density lipoprotein (LDL), an unidentified NMR
bucket at 0.835 ppm (edge weight = 0.184), age (edge weight = 0.179), an unidentified NMR bucket at 2.755 ppm (edge
weight = -0.138), an NMR bucket at 2.675 ppm (edge weight = -0.134), identified as citric acid, an NMR bucket at 1.925
ppm (edge weight = 0.131), identified as acetate (major signal) and minor contributions from arginine and lysine, and an
NMR bucket at 3.275 ppm (edge weight = 0.127), identified as trimethylamine-N-oxide (TMAO) and minor contributions
from D-glucose and betaine.
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Figure 13: Smooth scatter plot of randomly adjusted p-values (x -axis) versus unadjusted (univariate) p-values (y-axis)
for the univariate screening (a), and the MGM (b) in the test set.
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Figure 14: Effects of variable adjustment on univariate or MGM association analysis in the test set. (a) “top assoc.”
shows the distribution of − log10(p-values) derived from a univariate regression. Here, we calculated p-values between all
possible pairs of variables and collected all top associations. (a) “top neigh.” shows the analogous distribution, where the
top feature was selected by largest absolute regression weight in the MGM neighborhood. (b) The corresponding plot,
where the p-values were corrected by the top five confounder variables of the univariate and MGM screening, respectively.
(c) The corresponding plot, where we adjusted for the same five randomly selected features for both methods.
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Figure 15: (a) to (c) show the differences between “top neigh.” and “top assoc.” in Figure 14a to c, respectively:
(a) shows the − log10(p-values) of the MGM approach minus those of the univariate screening in Figure 14a, (b) shows
the corresponding plot after adjusting for the respective top confounders, as shown in Figure 14b, and (c) shows the
corresponding plot for adjusting for the randomly selected confounders, as shown in Figure 14c. The red point in each
figure contrast the values on the y-axis with their respective rank. On the x -axis, the highest positive difference correspond
to 1 and the most negative to 0. The green shaded areas correspond to rank percentiles of negative, the violet shaded areas
correspond to rank percentiles of positive differences.
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Figure 16: Smooth scatter plot of adjusted p-values (x -axis) versus unadjusted (univariate) p-values (y-axis) for the
univariate screening (a), and the MGM (b) in the test set.
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Figure 17: Boxplots comparing NMR signal intensities at 3.275ppm, which comprises NMR signals from trimethylamine-
N-oxide (TMAO) (major), as well as minor signals from D-glucose and betaine. Log2-transformed NMR signal intensities for
patients with (card arr) and without cardiac arrhythmia (no card arr) for both training (a) and test data (c), respectively,
are shown. The residuals of log2-transformed NMR signal intensities after adjustment for BMI, systolic blood pressure,
smoking status, and diabetes status for both training (b) and test data (d) are shown. P -values of corresponding t-tests
are displayed above the boxes.
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